|106.47||+1.03 / +0.98%|
Data as of 3:59pm ET
|106.47||0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 113.00, with a high estimate of 129.00 and a low estimate of 110.00. The median estimate represents a +6.13% increase from the last price of 106.47.
The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.